D. Yerlioğlu, "Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab," ESPGHAN 52nd Annual Meeting , Glasgow, United Kingdom, pp.117, 2019
Yerlioğlu, D. 2019. Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab. ESPGHAN 52nd Annual Meeting , (Glasgow, United Kingdom), 117.
Yerlioğlu, D., (2019). Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab . ESPGHAN 52nd Annual Meeting (pp.117). Glasgow, United Kingdom
Yerlioğlu, Dilay. "Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab," ESPGHAN 52nd Annual Meeting, Glasgow, United Kingdom, 2019
Yerlioğlu, Dilay Y. . "Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab." ESPGHAN 52nd Annual Meeting , Glasgow, United Kingdom, pp.117, 2019
Yerlioğlu, D. (2019) . "Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab." ESPGHAN 52nd Annual Meeting , Glasgow, United Kingdom, p.117.
@conferencepaper{conferencepaper, author={Dilay YERLİOĞLU AK}, title={Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on Adalimumab}, congress name={ESPGHAN 52nd Annual Meeting}, city={Glasgow}, country={United Kingdom}, year={2019}, pages={117} }